This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yan, L.
Right arrow Articles by Chen, Z. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yan, L.
Right arrow Articles by Chen, Z. W.

 Previous Article  |  Next Article 

Infection and Immunity, August 2008, p. 3439-3450, Vol. 76, No. 8
0019-9567/08/$08.00+0     doi:10.1128/IAI.00245-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Selected prfA* Mutations in Recombinant Attenuated Listeria monocytogenes Strains Augment Expression of Foreign Immunogens and Enhance Vaccine-Elicited Humoral and Cellular Immune Responses{triangledown}

Lin Yan,1,2,{dagger} Jin Qiu,1,2,{dagger} Jianbo Chen,1,2,3,{dagger} Bridgett Ryan-Payseur,1,2 Dan Huang,1,2 Yunqi Wang,1,2 Lijun Rong,1 Jody A. Melton-Witt,4 Nancy E. Freitag,1 and Zheng W. Chen1,2*

Department of Microbiology and Immunology,1 Center for Primate Biomedical Research, University of Illinois College of Medicine, Chicago, Illinois 60612,2 Department of Microbiology, Sun Yat-sen University, Guangzhou, China 510080,3 Department of Molecular and Cell Biology, University of California, Berkeley, California 94720-32024

Received 20 February 2008/ Returned for modification 5 April 2008/ Accepted 22 April 2008

While recombinant Listeria monocytogenes strains can be explored as vaccine candidates, it is important to develop attenuated but highly immunogenic L. monocytogenes vaccine vectors. Here, prfA* mutations selected on the basis of upregulated expression of L. monocytogenes PrfA-dependent genes and proteins were assessed to determine their abilities to augment expression of foreign immunogens in recombinant L. monocytogenes vectors and therefore enhance vaccine-elicited immune responses (a prfA* mutation is a mutation that results in constitutive overexpression of PrfA and PrfA-dependent virulence genes; the asterisk distinguishes the mutation from inactivation or stop mutations). A total of 63 recombinant L. monocytogenes vaccine vectors expressing seven individual viral or bacterial immunogens each in nine different L. monocytogenes strains carrying wild-type prfA or having prfA* mutations were constructed and investigated. Mutations selected on the basis of increased PrfA activation in recombinant L. monocytogenes prfA* vaccine vectors augmented expression of seven individual protein immunogens remarkably. Consistently, prime and boost vaccination studies with mice indicated that the prfA(G155S) mutation in recombinant L. monocytogenes {Delta}actA prfA* strains enhanced vaccine-elicited cellular immune responses. Surprisingly, the prfA(G155S) mutation was found to enhance vaccine-elicited humoral immune responses as well. The highly immunogenic recombinant L. monocytogenes {Delta}actA prfA* vaccine strains were as attenuated as the recombinant parent L. monocytogenes {Delta}actA vaccine vector. Thus, recombinant attenuated L. monocytogenes {Delta}actA prfA* vaccine vectors potentially are better antimicrobial and anticancer vaccines.


* Corresponding author. Mailing address: MC790, 909 S. Wolcott Ave., Chicago, IL 60612. Phone: (312) 355-0531. Fax: (312) 996-6415. E-mail: zchen{at}uic.edu

{triangledown} Published ahead of print on 12 May 2008.

Editor: A. J. Bäumler

{dagger} L.Y., J.Q., and J.C. contributed equally to this work.


Infection and Immunity, August 2008, p. 3439-3450, Vol. 76, No. 8
0019-9567/08/$08.00+0     doi:10.1128/IAI.00245-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.